Oragenics Inc. (OGEN) Fundamentals

Oragenics Inc is engaged in the healthcare sector. The firm is focused on becoming a leader in developing novel antibiotics against infectious diseases and on developing effective treatments for oral mucositis. Oragenics involves developing its antibiotic product candidate, OG716 as well as other homolog antibiotic product candidates, researching LBPs, and having other product candidates, including SMaRT Replacement Therapy positioned for out-licensing or partnering. It is also developing a Terra CoV-2 immunization product candidate to combat the novel coronavirus.
SHARE INFORMATION
Market Cap$ 32,590,546
Shares Outstanding116,394,806
Float113,700,804
Percent Float97.69%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 86,987
Latest Fiscal EPS$ -0.14
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions55
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months1,063,716
Institutional Holdings Percent19.5%
Institutional Sold Previous 3 Months1,055,462
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months1,020,000
Insider Holdings Percent6.0
Insider Sold Previous 3 Months-
Insider Shares Owned7,024,550
TRADING INFO
52 Week High$ 1.15
52 Week Low$ 0.22
52 Week High Change$ -56.92
21 Day Moving Average$ 0.2925
21 Day Extended Moving Average$ 0.292465
50 Day Moving Average$ 0.3327
50 Day Extended Moving Average$ 0.32634
200 Day Moving Average$ 0.488807
200 Day Extended Moving Average$ 0.463771
10 Day Average Volume434,487
20 Day Average Volume477,384
30 Day Average Volume458,230
50 Day Average Volume693,759
Alpha0.003265
Beta0.1128
Standard Deviation0.353938
R20.000228
7 Day Price Change$ 0.0131
7 Day Percent Change4.91%
21 Day Price Change$ -0.0406
21 Day Percent Change-12.66%
30 Day Price Change$ -0.0748
30 Day Percent Change-21.08%
Month to Date Price Change$ -0.0503
Month to Date Percent Change-15.23%
Quarter to Date Price Change$ -0.0645
Quarter to Date Percent Change-18.72%
180 Day Price Change$ -0.2489
180 Day Percent Change-47.06%
200 Day Price Change$ -0.3538
200 Day Percent Change-55.82%
Year to Date Price Change$ -0.166
Year to Date Percent Change-37.22%

Oragenics Inc. (OGEN) Key Ratios

PROFITABILITY
EBIT Margin-18,980.6%
EBITDA Margin-18,938.1%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 86,987
Revenue Per Share$ 0.0007
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.90
Total Debt To Equity0.00
Int Coverage-1,004.70
Current Ratio15.40
Leverage Ratio1.20
Quick Ratio15.20
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio-2.10
Enterprise Value$ 15,432,789
Price to Sales374.66
Price to Free Cash-2.30
PE High Last 5 Years-1.20
Price To Book1.90
Price To Cash Flow0.00
PE Low Last 5 Years-1.30
Price to Tangible Book1.90
MANAGEMENT EFFECTIVENESS
Receivables Turnover24.90
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-57.50
Return on Equity-66.89
Return on Capital-63.05

Oragenics Inc. (OGEN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMayer Hoffman McCann P.C.
CEOMichael OKeefe Sullivan
Emplyoees5
Last AuditUE
CIK0001174940
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address4902 Eisenhower Boulevard
Suite 125
Tampa, FL 33634
Websitehttps://www.oragenics.com
Facsimile+1 813 286-7904
Telephone+1 813 286-7900
Emailjohnm@coreir.com


Your Recent History
AMEX
OGEN
Oragenics
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.